How Roe Ruling is Hindering Access to Cancer & Arthritis Drug
The recent Supreme Court’s decision to overturn Roe v. Wade isn’t just suppressing access to Plan B and abortion pills: The Washington Post and Time have reported consumers raising alarms about chemotherapy and autoimmune drug.
The reason? Methotrexate, an FDA-approved drug used to treat rheumatoid arthritis and psoriasis, can also terminate a pregnancy. People who have prescriptions for methotrexate, which can also be used to treat some cancers, have said on social media they’re having trouble accessing the drug.
“Roe was overturned 6 days ago,” one person tweeted. “in less than one week, I lost access to healthcare that I need because the drug could be used to induce abortions.”
And with some state legislators tightening restrictions on emergency contraceptives and medication abortion — with the former preventing ovulation and the latter inducing an abortion — other drugs could soon be in the crossfire.
Roe v. Wade, 410 U.S. 113 (1973) was a landmark decision of the U.S. Supreme Court in which the Court ruled that the Constitution of the United States conferred the right to choose to have an abortion. The decision struck down many federal and state abortion laws, and fueled an ongoing abortion debate in the United States about whether, or to what extent, abortion should be legal, who should decide the legality of abortion, and what the role of moral and religious views in the political sphere should be. The decision also shaped debate concerning which methods the Supreme Court should use in constitutional adjudication.
On June the 24th The U.S Supreme Court voted to strike down the landmark Roe v. Wade decision, eliminating the constitutional right to abortion after almost 50 years.
